Since the introduction of highly active antiretroviral (ARV) therapy in the United States in the mid-1990s (1-3), the life expectancy of U.S. children who were infected perinatally with human immunodeficiency virus (HIV) has increased substantially. As a result, the number of perinatally HIV-infected females in the United States who are becoming both sexually active and pregnant is increasing (4). During August 1998-May 2002, a total of 10 pregnancies were identified among eight perinatally HIV-infected adolescents and young adults in Puerto Rico; in April 2002, the Puerto Rico Department of Health (PRDOH) asked CDC to assist in assessing such pregnancies. This report describes these pregnancies and discusses factors associated with sexual activity and pregnancy. The findings suggest that increasing numbers of pregnancies will occur among perinatally HIV-infected adolescents and young adults and that appropriately tailored reproductive health interventions should be developed.
Since the introduction of highly active antiretroviral (ARV) therapy in the United States in the mid-1990s (1-3), the life expectancy of U.S. children who were infected perinatally with human immunodeficiency virus (HIV) has increased substantially. As a result, the number of perinatally HIV-infected females in the United States who are becoming both sexually active and pregnant is increasing (4) . During August 1998-May 2002, a total of 10 pregnancies were identified among eight perinatally HIV-infected adolescents and young adults in Puerto Rico; in April 2002, the Puerto Rico Department of Health (PRDOH) asked CDC to assist in assessing such pregnancies. This report describes these pregnancies and discusses factors associated with sexual activity and pregnancy. The findings suggest that increasing numbers of pregnancies will occur among perinatally HIV-infected adolescents and young adults and that appropriately tailored reproductive health interventions should be developed.
Adolescents and young adults were identified by their healthcare providers or by PRDOH, and chart reviews and interviews were conducted during April-August 2002. For females with two pregnancies, interview and chart data on the first pregnancy are reported. Case-patients were defined as perinatally HIV-infected adolescents or young adults with a history of pregnancy, and controls were defined as perinatally HIV-infected females with no history of pregnancy. All controls were age-matched to <1 year of the age of the pregnant females, except for one patient aged 22 years who had been aged 19 years when she was pregnant; she was matched to a control aged 19 years. Perinatal infection was defined as confirmed HIV-positive serostatus of the patient's biologic mother or an HIV risk factor for the biologic mother and the absence of any other risk factors (e.g., sexual abuse or blood transfusions) for the patient.
A total of eight case-patients were identified in four cities in Puerto Rico. The median age of the case-patients was 18 years (range: 15-22 years), and the median age at the time of first pregnancy was 17 years (range: 13-19 years). Among the 10 pregnancies to the eight patients, seven pregnancies in six patients resulted in live-born infants; as of February 24, no cases of mother-to-child HIV transmission were reported. In addition, two pregnancies ended in elective abortions and one in a spontaneous abortion.
Five case-patients had first pregnancies that resulted in liveborn infants; all five received some prenatal care, and four (80%) received ARV therapy consistently during their pregnancies. All infants received zidovudine prophylaxis after delivery. The median viral load of these case-patients during pregnancy was 35,822 copies/mL (range: 3,535-163,064 copies/mL), and the median CD4 count during pregnancy was 218 cells/mm 3 (range: 19-956 cells/mm 3 ). The majority of the case-patients were highly ARV-experienced, with a median of >9 years (range: 3-12 years) of ARV therapy, and five case-patients had each taken at least nine different ARV medications during their lifetimes. All four case-patients who were tested for viral resistance had multiple genotypic mutations.
Five of the eight case-patients reported unintended pregnancies, and two reported using condoms as a form of birth control at the time they conceived. Six case-patients are now living with partners; one is in school, two left school because they were pregnant, and five left for reasons other than pregnancy or motherhood. Eight controls were included in the analysis. The median age of case-patients and of controls at the time they were interviewed was 18 years (range: 15-22 years) and 17 years (range: 14-19 years), respectively. The median age of HIV diagnosis was 7 years (range: 0-13 years) for case-patients and 4 years (range: 2-13 years) for controls. Differences in clinical outcomes included a median viral load since 1999 of 16,263 copies/mL (range: 5,251-65,571 copies/mL) for casepatients and of 53,071 copies/mL (range: 54-476,139 copies/ mL) for controls and a median CD4 count since 1999 of 251 cells/mm 3 (range: 72-1,296 cells/mm 3 ) for case-patients and of 293 cells/mm 3 (range: 66-1,002 cells/mm 3 ) for controls.
Behavioral and social characteristics associated with sexual activity and pregnancy were compared for all 16 case-patients and controls; all eight case-patients and two controls who reported being active sexually were asked questions about sexual activity. More case-patients than controls had dropped out of school before pregnancy and had friends who had become pregnant before they did (Table) . The mean age when they were first told their HIV status was 13 years (range: 12-15 years) for case-patients and 12 years (range: 8-14 years) for controls. The median age at first sexual activity was 15 years (range: 13-18 years) for case-patients and 17 years (range: 15-18 years) for controls. The median time that elapsed between being told their HIV status and becoming sexually active was 2 years (range: 0-5 years) for case-patients and 5 years (range: 4-6 years) for controls. Three case-patients and no controls became sexually active at the same age that they were first told their HIV status.
Editorial Note: This report describes pregnancies in perinatally HIV-infected adolescents and young adults for the first time and highlights the challenges in developing appropriately tailored reproductive health services for this growing population in the United States. During the early 1980s, when the first perinatally acquired AIDS cases were documented, infection in the majority of children progressed rapidly to death. Therefore, these children were not expected to survive to adolescence and mature to become sexually active. The findings of this investigation suggest that the risk-taking sexual behaviors of perinatally HIV-infected adolescents and young adults might not differ from those of non-HIV-infected adolescents and young adults (5, 6) . Although ARV therapy has made perinatal HIV transmission in this population infrequent in the United States (7), as the perinatally HIV-infected population ages, increasing numbers of pregnancies in perinatally HIV-infected female adolescents and young adults can be anticipated, and reproductive health issues affecting this population will need to be addressed.
Factors that might be associated with pregnancy in these females include a relatively late age at disclosure of HIV status and inconsistent condom use with sex partners. These findings underscore the need for early disclosure of HIV status to infected adolescents and young adults and for increased discussions about sexual risk reduction among all perinatally infected adolescents and young adults. Providing families with the tools for HIV disclosure to children and for reproductive health discussions before sexual initiation might reduce risky behaviors among these females.
The findings in this report are subject to at least two limitations. First, the small sample size makes the findings largely descriptive. Second, matching by age might not reflect social or physical development. Both of these limitations reduce the degree to which generalizations can be based on the data. Enhanced efforts to identify pregnancies among perinatally HIV-infected adolescents and young adults and more in-depth investigation of such pregnancies could better characterize the factors associated with pregnancies and birth outcomes.
The finding of genotypic mutations of HIV isolated in all persons tested in Puerto Rico reinforces the importance of preventing secondary HIV transmission both to infants and sex partners. Surveillance of birth outcomes in perinatally HIV-infected adolescents and young adults and of cases of mother-to-child transmission and transmission of drugresistant virus should continue. To permit accurate monitoring of trends in HIV transmission, clinicians should report births to HIV-infected women and adolescents to their health departments according to state surveillance guidelines for HIV/AIDS reporting. In addition, to assist CDC with determining pregnancy outcomes among this population, clinicians are urged to report pregnancies among perinatally HIV-infected adolescents and young adults directly to CDC, telephone, 404-639-6141, or e-mail, mmcconnell@cdc.gov, through June 2003.
MMWR February 28, 2003

Secondhand Smoke Exposure Among Middle and High School Students -Texas, 2001
Secondhand smoke (SHS) exposure causes approximately 3,000 deaths each year in Texas (1, 2) and is associated with increased morbidity caused by acute respiratory infections and asthma among children and respiratory problems among adults (3, 4) . Adult lung cancer risk might be increased as a result of SHS exposure during childhood and adolescence (5) . To assess SHS exposure among middle and high school students in Texas, the Texas Department of Health (TDH) analyzed data from the 2001 Texas Youth Tobacco Survey (TYTS). This report summarizes the results of that analysis, which indicate that half of 8,687 middle school students and two-thirds of 8,696 high school students reported SHS exposure within the 7 days preceding the survey. The prevalence of SHS exposure was higher among students who reported living with a cigarette smoker or having at least one close friend who smokes. Among middle school students, the prevalence of SHS exposure was lower among those who perceived SHS to be harmful to their health. These findings emphasize the need for continuing efforts to decrease SHS exposure among youth and to increase understanding of the harmful health effects of SHS exposure.
During fall 2001, TDH conducted the third TYTS. The survey uses a two-stage cluster sample design to produce representative samples of middle and high school students in Texas public schools. The primary sampling units were public schools with students in grades 6-12. Schools were stratified into middle schools (grades 6-8) and high schools (grades 9-12), and two separate samples were drawn. Schools were selected for participation in the survey with a probability proportional to the number of students enrolled. The secondary sampling units were classes selected randomly within schools that agreed to participate. All students in the selected classes, regardless of tobacco-use status, were eligible to participate in the survey. Students completed an anonymous, selfadministered questionnaire that included questions on demographics, tobacco use, tobacco-related knowledge and attitudes, media messages about tobacco use, access to tobacco, tobacco-related school curriculum, SHS, and tobacco-use cessation. Data were weighted to adjust for nonresponse at both the student and school level and to provide generalizable estimates for Texas public school students according to grade, sex, and race/ethnicity. To assess SHS exposure, TYTS asked students to report how many days they had been in the same room or riding in a car with someone who was smoking cigarettes during the 7 days preceding the survey. SHS exposure was compared among middle and high school students by demographics, tobacco use, presence of close contacts who smoke, and attitudes toward SHS. SUDAAN (version 8.0) was used to calculate prevalence estimates and standard errors for 95% confidence intervals (CIs).
A total of 17,383 students from 192 schools participated in the 2001 TYTS. The overall response rate, a product of the school and individual student response rates, was 64.5%. The response rates were 71.3% for middle schools and 60.3% for high schools.
During 2001, the prevalence of SHS exposure increased with grade: 50.6% (95% CI = +3.1%) of middle school students reported SHS exposure compared with 65.8% (95% CI = +2.2%) of high school students. Asians/Pacific Islanders (42.0%; 95% CI = +9.0%) were less likely than other racial/ ethnic groups to report SHS exposure. The prevalence of SHS exposure did not differ significantly among blacks (56.0%; 95% CI = +4.3%), Hispanics (58.1%; 95% CI = +1.8%), whites (62.0%; 95% CI = +3.8%), or other racial/ethnic groups (60.5%; 95% CI = +5.2%). Overall, 73.5% (95% CI = +1.7%) of students who had ever used any tobacco product reported SHS exposure, compared with 39.5% (95% CI = +2.5%) of students who never used any tobacco product. Among students who lived with a cigarette smoker, 80.1% (95% CI = +2.2%) reported SHS exposure compared with 43.9% (95% CI = +1.9%) of students who did not live with a cigarette smoker. Among students with no close friends who smoke, 42.0% (95% CI = +2.0%) reported SHS exposure compared with 79.0% (95% CI = +1.6%) of students with at least one close friend who smokes. The prevalence of SHS exposure was 29.7% (95% CI = +1.1%) among students with no social sources of SHS exposure (i.e., those who did not live with a smoker or did not have any close friends who smoke), compared with 90.7% (95% CI = +2.1%) who lived with a smoker and had at least one close friend who smokes.
Students' perception of SHS exposure being harmful to their health varied slightly. Overall, the prevalence of SHS exposure was 58.5% (95% CI = +1.9%) among students who perceived SHS to be harmful to their health, compared with 63.6% (95% CI = +3.7%) of students who did not think SHS was harmful. Among middle school students, those who perceived SHS to be harmful to their health were statistically less likely to report SHS exposure than students who did not think SHS was harmful (Table) . Among high school students, perceptions of the health risks for SHS exposure did not affect personal SHS exposure. * N = 17,383; middle school students (n = 8,687), high school students (n = 8,696). † Confidence interval. § Students who lived with a smoker and had at least one close friend who smoked.
Editorial Note: The findings in this report indicate that, despite its known health hazards, SHS exposure among Texas students is common. Perceptions of the health hazards of SHS exposure were associated with less reported exposure among middle school students. Among students who reported living with a smoker and having at least one close friend who smokes, the prevalence of SHS exposure was three-fold that of students who did not have these social SHS exposures. Even among students without any social sources of SHS exposure, approximately one third reported that they were exposed to SHS. These findings suggest that reducing youth exposure to SHS requires strategies such as policies that limit SHS exposure and interventions to decrease youth tobacco-use initiation and to promote tobacco-use cessation among youth and adults. Serum cotinine levels, a measure of SHS exposure, are higher among youth than among adults in the United States (6), which underscore the need to reduce SHS exposure, especially among youth. Several communities in Texas have passed ordinances that restrict indoor smoking, including a total ban on indoor smoking in all public places in El Paso and a recent ordinance in Dallas that bans indoor smoking in all public places except freestanding bars. In addition, the Environmental Protection Agency has developed the Smoke-Free Home Pledge Initiative, a campaign to reduce SHS exposure among children in their homes (http://www.epa.gov/ smokefree/index.html). These initiatives might help reduce SHS exposure both in the community and at home.
The findings in this report are subject to at least three limitations. First, the data are representative only of Texas students who attend public schools and might not apply to students who have dropped out of school or who are enrolled in private schools. During the 1999-00 school year, the average dropout rate for Texas public school students enrolled in grades 7-12 was 1.3% (7) . In addition, approximately 10% of middle and high school students are enrolled in private schools (8) . Second, because TYTS data are self-reported and anonymous, the validity of the responses is difficult to assess. Studies attempting to validate self-reported smoking among youth suggest that the sensitivity of selfreported data on tobacco use is approximately 81% (9). Finally, TYTS asked only if students had been in the same room or car with someone who was smoking during the preceding 7 days. Details about how youths are exposed to SHS, including where the exposure occurs and whether youths are exposed more commonly to SHS from household members, parents, or friends, would help in targeting tobacco-control programs designed to reduce SHS exposure.
Effective strategies to reduce SHS exposure include 1) community policies such as smoking bans and restrictions that limit SHS exposure, 2) interventions to decrease youth tobacco-use initiation, and 3) interventions to promote tobacco-use cessation among youth and adults (10). The data
MMWR February 28, 2003
presented in this report underscore the need for increased efforts to implement these strategies to reduce SHS exposure among youths and prevent the negative health effects of SHS exposure.
Ambulance Crash-Related Injuries Among Emergency Medical Services Workers -United States, 1991-2002
Ambulance crashes are one of many hazards faced by Emergency Medical Services (EMS) personnel. Although no complete national count of ground ambulance crashes exists, the total number of fatal crashes involving ambulances can be ascertained by using the National Highway Traffic Safety Administration (NHTSA) Fatality Analysis Reporting System (FARS). To characterize risk factors for EMS workers involved in ambulance crashes, CDC's National Institute for Occupational Safety and Health (NIOSH) and NHTSA investigated three case reports of ambulance crashes. This report summarizes these investigations, presents surveillance data, and discusses recommendations for prevention measures. NIOSH is identifying and testing alternative measures to reduce injury risk for EMS workers.
Case Reports
Case 1. In May 2001, an Emergency Medical Technician (EMT) aged 26 years died when her ambulance was struck head-on by a pick-up truck at 6:30 a.m. The EMT had been riding unrestrained in the patient compartment while attending a patient during a nonemergency transport. During the collision, the EMT struck the front bulkhead of the patient compartment; she died en route to the hospital from blunt force trauma to the head and chest. The patient and pick-up driver also suffered fatal injuries. The ambulance driver had been driving unrestrained and suffered multiple serious injuries, including a fractured leg.
Case 2. In July 2001, an EMT aged 27 years died when her ambulance struck an elevated train-track support column at 12:30 p.m. She had been riding unrestrained in the patient compartment while attending a patient during a nonemergency transport. During the collision, the EMT and the patient both struck the front bulkhead of the patient compartment. Both the driver and patient were hospitalized; the EMT was transported to a hospital, where she was pronounced dead.
Case 3. In March 2002, an EMT aged 22 years who was driving and a paramedic aged 37 years were injured when their ambulance struck an oncoming vehicle head-on and overturned. The paramedic was riding unrestrained on the patient compartment squad bench while attending a patient during a nonemergency transport. A relative of the patient was seated in the rear-facing attendant's seat and was wearing a seatbelt. During the collision, the unrestrained EMT driver sustained minor injuries. The paramedic struck the interior cabinets and shelves of the patient compartment. The EMT and the paramedic were transported to a hospital, where the EMT was treated and released; the paramedic was hospitalized and released 2 days later. The patient's injuries included scalp and shoulder contusions and a shoulder laceration. The patient's relative sustained minor internal injuries. * A total of 14 fatalities occurred among driver's seat occupants; two of them were coded "unknown" for "fatal injury at work," and a third was coded "no." Although an ambulance driver might be an EMS worker, only those coded positively for "fatal injury at work" were included as EMS workers.
Surveillance Data
During 1991-2000, the most recent year for which data were available, 300 fatal crashes occurred involving occupied ambulances, resulting in the deaths of 82 ambulance occupants and 275 occupants of other vehicles and pedestrians. The 300 crashes involved a total of 816 ambulance occupants. FARS does not differentiate ambulance workers from passengers among those experiencing nonfatal injuries in fatal crashes; however, the seating positions for all occupants and the severity of injuries can be determined from FARS data (Table) .
Although which occupants were EMS workers and which were patients or other passengers cannot be ascertained precisely, calculations using the FARS "fatal injury at work" variable based on death certificate information indicate that 27 of the occupants killed were on-duty EMS workers. These comprised 3% of all ambulance occupants and 33% of occupant fatalities.
The majority of the 27 EMS worker fatalities occurred in the front of the vehicle: 11 (41%) in the driver's seat and five (19%) in the front right-side seat.* Those coded as "other enclosed" accounted for seven (26%) of the EMS worker fatalities; these persons probably were working in the patient compartment. Four EMS workers were listed in "other/ unknown" seating positions (Table) . Editorial Note: EMS personnel in the United States have an estimated fatality rate of 12.7 per 100,000 workers, more than twice the national average (1). This report documents 27 ambulance crash-related fatalities among EMS workers over a 10-year period. The surveillance data and case investigations identify riding unrestrained as an important risk factor for EMS workers. Among all ambulance occupants, riding in the patient compartment was associated with greater injury severity. However, in 27 incidents coded as "fatal injury at work," seven (26%) of the EMS workers killed were drivers who were not wearing a restraint, and two (7.4%) were unrestrained in the front right seat. Six (22%) of the EMS workers killed were not wearing restraints while riding in the patient compartment.
In 1966, the National Academy of Sciences cited deficiencies at various levels of emergency care, including unsuitable ambulances with inadequate equipment, incomplete supplies, untrained attendees, lack of traffic control, and lack of voice communication facilities (2) . Since 1966, substantial improvements have been made in communications systems, the routine use of modern lifesaving equipment, and the level of worker expertise. In addition, the amount of emergency care has increased in volume, in level of complexity, and in required competency of EMS workers (3). However, in January 1992, minimal workplace safety research was conducted for EMS personnel, and statistics related to worker characteristics and job duties were largely unavailable (4). According to a retrospective study investigating characteristics of fatal ambulance crashes during an 11-year period that emphasized emergency versus nonemergency use incidents, the majority of ambulance crashes occurred during emergency use, and rear compartment occupants were more likely to be injured than those in front (5) .
Less than half of EMS workers use restraints in the patient compartment (6) . In addition, lap-belt restraint systems commonly provided in patient compartments do not allow full access to the patient. When properly used, the squad bench lap belts position the EMS worker against the side wall, making it impossible for the worker to bend forward to access the patient. If the EMS worker needs to access the cabinets along the driver-side wall, the belts must be unbuckled to allow the worker to stand up. If CPR or other procedures such as intubation or insertion of IVs must be performed, EMS personnel might need to stand over or kneel near the cot. For these reasons, EMS workers often ride unrestrained, seated on the edge of the squad bench (7). In addition, unrestrained or improperly restrained patients who become airborne in a crash might pose an additional injury risk to EMS personnel and to themselves.
The findings in this report are subject to at least three limitations. First, FARS records only crashes involving a motor vehicle traveling on a traffic-way customarily open to the public that result in the death of a person (either a vehicle occupant or nonmotorist) within 30 days of the crash (8) . As a result, fatal crashes on private property (e.g., driveways, parking lots, or private roads) are excluded. Second, which ambulance occupants were EMS workers cannot be determined precisely by examining injuries by occupation code. EMS might be provided by local career or volunteer fire departments, private ambulance companies, or volunteer rescue services. Finally, data about nonfatal injuries to volunteer firefighters and EMS workers are not included routinely in occupational injury databases.
CDC recommends that EMS employers ensure that EMS workers use patient compartment vehicle occupant restraints whenever possible, ensure that drivers and front-seat passengers of EMS vehicles use the occupant restraints provided, consider equipping ambulances with patient cots that include upper body restraints, and ensure that EMS workers who operate ambulances are qualified and trained appropriately. Ambulance manufacturers should evaluate and develop occupant protection systems designed to increase the crash survivability of EMS workers and patients in ambulance patient compartments and ensure that such systems allow EMS workers mobility to access patients and equipment.
Smallpox Vaccine Adverse Events Among Civilians -United States, February 18-24, 2003
During the civilian smallpox vaccination program, CDC and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (1) (Table) . Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of February 21, 2003, and received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of February 24.
Potentially life-threatening and moderate-to-serious events are classified on the basis of evidence in support of the reported diagnoses. For probable cases, other causes are excluded, and supportive information is available. Events are classified as suspected if they have clinical features compatible with the diagnosis but either further investigation is required or additional investigation of the case did not provide supporting evidence for the diagnosis and did not identify an alternative diagnosis. CDC and state health departments also receive reports of other events that are associated temporally with smallpox vaccination. Reported adverse events are not necessarily associated with vaccination, and some or all of these events might be coincidental.
During January 24-February 21, smallpox vaccine was administered to 7,354 civilian health-care and public health with smallpox vaccination. The patient had onset of chest pain while playing tennis 4 days after smallpox vaccination and reported to an emergency department. The patient was diagnosed with right coronary artery occlusion, and an angioplasty was performed. He was discharged after being hospitalized for 2 days.
Among 23 vaccinees with reported other nonserious adverse events during January 24-February 24, the most common signs and symptoms were fever (n = six), pruritus (n = five), rash (n = four), vasodilation (n = four), asthenia (n = three), headache/ migraine (n = three), malaise (n = three), paresthesia (n = three), and redness at injection site (n = three). Some vaccinees reported multiple signs and symptoms.
Surveillance for adverse events during the civilian smallpox vaccination program is ongoing; regular surveillance reports will be published in MMWR. 
Notice to Readers
Availability of Maxi-Vac Smallpox Vaccination Software
Free copies of the Maxi-Vac software program are now available. Maxi-Vac allows officials to refine smallpox vaccination clinic human resource allocations (e.g., physicians, nurses, and other staff ) to maximize patient flow-through.
Maxi-Vac software and the accompanying manual can be downloaded at http://www.bt.cdc.gov/agent/smallpox/vaccination/maxi-vac. Operation of Maxi-Vac requires the use of Visual Basic Runtime v. 6.0, which also can be downloaded at the Maxi-Vac web page. The Maxi-Vac manual can be downloaded in either a Microsoft Word format or an Adobe Acrobat format. The Maxi-Vac software and manual are in the public domain and may be used and copied without permission; however, citation as to source is appreciated. workers in 40 jurisdictions. No potentially life threatening adverse events were reported as of February 24.
One moderate-to-severe adverse event was reported, a suspected case of generalized vaccinia in a woman aged 39 years. Nine days after receiving smallpox vaccine, the patient reported increased pain at the vaccination site, malaise, and headache. The following day, she developed a pruritic, papular rash on her chest and back that progressed to scattered pustules by day 12 following vaccination. She was treated as an outpatient with antihistamines, and the rash was resolving by day 15. Specimens from the pustular lesions were collected and sent for virologic testing; results are pending.
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